GLS4
PCD-DGLS4-18-002
Phase 2 small_molecule completed
Quick answer
GLS4 for Chronic HBV Infection is a Phase 2 program (small_molecule) at Sunshine Biopharma with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Sunshine Biopharma
- Indication
- Chronic HBV Infection
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed